Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 468 participants.

Also called NCT01255722

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose diagnostic
Phase
Phase 4
Enrolled
  • 468 participants (enrolled count) (from the registry)
Sponsor
  • Guerbet Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01255722
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
France, Germany, Italy, Spain, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01255722. Randomized; double masking; primary purpose diagnostic. Start 2010-11 (registry gives no type); primary completion 2012-09 (actual). Results posted on 2015-12-16.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography
Acronym
X-ACT
Intervention (Drug)
iobitridol
Intervention (Drug)
iopromide
Intervention (Drug)
iomeprol
Lead sponsor
Guerbet (class: industry)

Record details

Record id
cardio:ct-nct01255722
Content hash
b19154d8d536e3cf35c8438af125153197e770df868a3cfea4392966836528cf